Management of Viral URI/RSV in Children

Primary Benefits

Antipyretics provide symptomatic relief for children with fever and discomfort associated with viral URIs and RSV, helping manage high fevers (>38.5°C) and improving comfort while the self-limited illness runs its course 1, 2, 3
Antipyretics can help reduce pain associated with viral URIs, including headache, chest pain, arthralgia, and abdominal pain, and relief of pleural pain may improve the child's ability to cough effectively and breathe more deeply 3

The American Academy of Pediatrics recommends acetaminophen as the first-line antipyretic therapy for children due to its favorable safety profile, with standard dosing: 10-15 mg/kg every 4-6 hours, not exceeding 5 doses in 24 hours 4
Aspirin should not be used in children under 16 years of age due to the risk of Reye's syndrome 1, 2

No evidence is available to support the use of antipyretics in altering disease course or preventing complications, but they are essential for comfort 1, 2

Children with coughs and mild fevers from viral URIs including RSV should be managed at home with antipyretics and adequate fluids, and parents should be advised that nasal discharge color change is not indicative of bacterial infection 1, 2, 5, 6
Children with high fever (>38.5°C) and respiratory symptoms without high-risk features can be managed with antipyretics and fluids 1, 2
Children with signs of respiratory distress, severe dehydration, altered consciousness, or prolonged seizures should be referred for hospital assessment, where antipyretics remain important for comfort but should be part of comprehensive supportive care 2, 3

Antipyretics do not prevent febrile seizures or reduce their recurrence risk 4
Approximately 7-13% of children may have respiratory symptoms lasting more than 15 days, particularly those in daycare settings, and fever alone at day 10 is not suggestive of bacterial infection requiring antibiotics 5